Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$345M |
| 2 |
PNC Financial Services
PNC
|
+$325M |
| 3 |
Edison International
EIX
|
+$249M |
| 4 |
Veeva Systems
VEEV
|
+$241M |
| 5 |
Expedia Group
EXPE
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$300M |
| 2 |
Comcast
CMCSA
|
+$255M |
| 3 |
Airbnb
ABNB
|
+$201M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$177M |
| 5 |
Eli Lilly
LLY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25% |
| 2 | Financials | 15.05% |
| 3 | Consumer Discretionary | 12.44% |
| 4 | Healthcare | 12.08% |
| 5 | Industrials | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Lightwave Logic
LWLG
$954M
| $22.5K | ﹤0.01% |
18,121
-836
| -4% | -$878 |
|
3277
Roadzen
RDZN
$132M
| $21.7K | ﹤0.01% |
22,156
-18,403
| -45% | -$18.4K |
|
3278
Pacific Biosciences
PACB
$420M
| $21.1K | ﹤0.01% |
16,989
+6,067
| +56% | +$7.01K |
|
3279
Veru
VERU
$45M
| $20.9K | ﹤0.01% |
3,586
+1,788
| +99% | +$10K |
|
3280
Wolfspeed
WOLF
$1.34B
| $20.6K | ﹤0.01% |
+51,732
| New | +$118K |
|
3281
GrowGeneration
GRWG
$101M
| $20.4K | ﹤0.01% |
21,853
-3,585
| -14% | -$3.82K |
|
|
GBIO
3282
DELISTED
Generation Bio
GBIO
| $20.4K | ﹤0.01% |
6,369
-2,532
| -28% | -$9.75K |
|
3283
Harvard Bioscience
HBIO
$34.1M
| $20.3K | ﹤0.01% |
4,571
+2,293
| +101% | +$9.58K |
|
|
MRDN
3284
Meridian Holdings Inc
MRDN
$179M
| $19.4K | ﹤0.01% |
+952
| New | +$20.7K |
|
|
ELEV
3285
DELISTED
Elevation Oncology
ELEV
| $19K | ﹤0.01% |
51,672
-5,858
| -10% | -$1.96K |
|
3286
ALX Oncology
ALXO
$282M
| $18.9K | ﹤0.01% |
45,583
-73,467
| -62% | -$37.1K |
|
3287
Cibus
CBUS
$130M
| $17.4K | ﹤0.01% |
12,636
-26,550
| -68% | -$54K |
|
3288
Hyliion Holdings
HYLN
$595M
| $14.8K | ﹤0.01% |
11,225
-65,732
| -85% | -$95.8K |
|
3289
NeuroOne Medical Technologies
NMTC
$18.5M
| $7.1K | ﹤0.01% |
+1,745
| New | +$6.44K |
|
3290
Ovid Therapeutics
OVID
$547M
| $5.18K | ﹤0.01% |
15,705
+255
| +2% | +$77 |
|
3291
374Water
SCWO
$42.9M
| $3.83K | ﹤0.01% |
+1,181
| New | +$3.97K |
|
|
LNAI
3292
Lunai Bioworks
LNAI
$9.77M
| $3.01K | ﹤0.01% |
130
-120
| -48% | -$3.35K |
|
|
ADVM
3293
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-33,823
| Closed | -$148K |
|
3294
Ameresco
AMRC
$1.13B
| – | – |
-67,876
| Closed | -$820K |
|
|
AOD
3295
abrdn Total Dynamic Dividend Fund
AOD
$1.13B
| – | – |
-10,145
| Closed | -$85.1K |
|
3296
Anterix
ATEX
$1.83B
| – | – |
-11,489
| Closed | -$420K |
|
3297
ATN International
ATNI
$477M
| – | – |
-22,584
| Closed | -$459K |
|
|
JBIO
3298
Jade Biosciences
JBIO
$1.36B
| – | – |
-618
| Closed | -$54.3K |
|
3299
Axogen
AXGN
$2.71B
| – | – |
-23,917
| Closed | -$442K |
|
3300
Alibaba
BABA
$286B
| – | – |
-1,923
| Closed | -$254K |
|
Similar funds
Cliff Asness's Q2 2025 Portfolio in Review
As of Q2 2025, Cliff Asness held 3,434 positions worth $121B, up 25% from $97.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $14B of net new capital in Q2 2025, opening 284 new positions and adding to 1,844 existing holdings. Its largest new stake was Reddit: 531,663 shares worth $80.1M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was ConocoPhillips, an estimated $300M trimmed.
- Cliff Asness's largest Q2 2025 buy was Reddit: 531,663 shares worth $80.1M.
- Cliff Asness added most to Monster Beverage in Q2 2025, an estimated $345M increase.
- Cliff Asness's biggest Q2 2025 reduction was ConocoPhillips, cutting an estimated $300M.
- Cliff Asness fully exited Discover Financial Services in Q2 2025, selling an estimated $36.3M.
- Cliff Asness's ten largest holdings make up 12% of its $121B portfolio in Q2 2025.
- Cliff Asness opened 284 new positions and closed 142 in Q2 2025.
- Cliff Asness's portfolio value rose 25% quarter-over-quarter to $121B.
Based on AQR Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.